Satsuma Pharmaceuticals, Inc. announced that Immediately following the Effective Time Tom O'Neil ceased serving as Chief Financial Officer of the Company.
Satsuma Pharmaceuticals, Inc.
Equities
STSA
US80405P1075
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+15.41% | 121B | |
+13.48% | 107B | |
-5.06% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.47% | 15.31B | |
+2.93% | 14.08B | |
+24.84% | 11.74B |